EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 26 filers reported holding EFFECTOR THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,025,047 | -28.0% | 6,822,114 | 0.0% | 2.06% | -14.5% |
| Q2 2023 | $5,594,133 | +134.3% | 6,822,114 | 0.0% | 2.41% | +171.3% |
| Q1 2023 | $2,387,740 | -18.6% | 6,822,114 | 0.0% | 0.89% | -17.0% |
| Q4 2022 | $2,933,509 | -24.6% | 6,822,114 | 0.0% | 1.07% | -39.8% |
| Q3 2022 | $3,889,000 | -59.9% | 6,822,114 | 0.0% | 1.78% | -62.5% |
| Q2 2022 | $9,687,000 | -64.6% | 6,822,114 | 0.0% | 4.74% | -66.1% |
| Q1 2022 | $27,357,000 | -51.6% | 6,822,114 | 0.0% | 14.00% | -56.1% |
| Q4 2021 | $56,487,000 | – | 6,822,114 | – | 31.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,822,114 | $67,027,000 | 15.21% |
| Column Group LLC | 4,309,329 | $60,546,000 | 6.89% |
| SECTORAL ASSET MANAGEMENT INC | 2,882,744 | $40,503,000 | 3.37% |
| Blackstone Inc. | 1,308,587 | $18,386,000 | 0.04% |
| Virtu Financial LLC | 17,444 | $245,000 | 0.02% |
| Verition Fund Management LLC | 24,667 | $347,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 6,859 | $97,000 | 0.00% |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 430 | $6,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 24,005 | $337,000 | 0.00% |